Instrument companies appear to be gearing up to expand their microarray offerings into regulated markets. So far this year, three companies have made announcements regarding FDA 510(k) submissions of their cytogenetic microarray products. And just this week, PerkinElmer purchased a provider of clinical cytogenetic microarray testing services (see page 2). The news illustrates the rapid […]
In a year destabilized by capital constraints, lower R&D spending and order delays, a new leader emerged as the largest provider of analytical and life science instruments and aftermarket products, based on IBO’s annual calculation. Life Technologies, which resulted from the merger between Invitrogen and Applied Biosystems (see IBO 6/15/08), further expanded its leadership in […]
A focused approach has paid off for febit biotech GmbH. Febit biotech was founded in 2005 after disagreements between investors led to the closing of febit AG in 2004. Febit AG’s intellectual property, production technology, product line and name were purchased by former investors to create febit biotech. Febit is focused on two main application […]
New laboratory construction in late 2009 and early 2010 was driven by both public and private expenditures. New laboratory plans included a continuing flow of bioscience university projects in the US, as well as government-coordinated national projects worldwide. R&D laboratories for agricultural biotechnology companies and new labs for consumer products companies were also announced. Among […]
Fourth-quarter sales for the IBO Lab Equipment/Consumables Index climbed 8.3% to $922.96 million, including 2.4% growth from currency. Median growth was 6.3%. Operating profit grew 14.7% to $305.37 million. Operating margins improved 190 basis points to 33.1% of sales. The median operating profit margin was 17.5%. For the year, Index sales slipped 1.6% to $3,478.49 […]
In the February 15 issue, IBO detailed R&D reorganizations at major pharmaceutical companies. Since then, Merck has announced its 2009 results, including a new Merger Restructuring Program. The Program addresses the combined operations of Merck and Schering-Plough, which Merck acquired in November 2009. Merck plans to cut 15% of its 100,000 employees by the end […]
Financials for the IBO Laboratory Sales Index have been updated from the numbers that appeared in the February 28 issue now that all the companies in the Index, except for Oxford Instruments, have reported calendar-year fourth-quarter and year-end results. For the fourth quarter, Laboratory Sales Index sales grew 6.9% to $4,985.89 million, including 5.1% growth […]
The US equity markets enjoyed another relatively unabated month as the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 5.1%, 5.9% and 7.1%, respectively. The Dow hit an 18-month high on March 30, not far from the 11,000 mark. While there are a number of positive economic data to support the recovery, such as […]
Atomic Spectroscopy Bruker AXS launched the D8 DISCOVER X-ray diffractometer. The D8 DISCOVER further increases ease of use with real-time component detection, plug-and-play functionality and fully integrated two-dimensional X-Ray Diffraction (XRD) capabilities. These capabilities allow the user to switch between all materials research XRD applications, including reflectometry, high-resolution diffraction, grazing incidence diffraction and small angle […]
In late March, the US Administration’s Office of Science and Technology Policy published its summary of research infrastructure funding in President Obama’s fiscal 2011 budget (October 1, 2010–September 30, 2011). The budget request is likely to be changed before it is approved by Congress; therefore, initial figures for fiscal 2011 are incomplete. However, the report […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
